Company Filing History:
Years Active: 2021
Title: Innovations of Hong-Yi Chang in Alzheimer's Disease Treatment.
Introduction
Hong-Yi Chang is a notable inventor based in Tainan, Taiwan. He has made significant contributions to the field of biomedical research, particularly in the area of Alzheimer's disease treatment. His innovative approach focuses on the use of curcumin derivatives, which have shown promise in preventing and treating this debilitating condition.
Latest Patents
Hong-Yi Chang holds a patent for the "Uses of curcumin derivative." This invention provides a method for preventing and/or treating Alzheimer's disease in a subject in need of such treatment. The method involves administering an effective amount of a curcumin derivative, specifically TML-6, along with a pharmaceutically acceptable carrier or excipient. This patent highlights his commitment to advancing medical science and improving patient outcomes.
Career Highlights
Chang is associated with Merry Life Biomedical Company, Ltd., where he continues to work on innovative solutions in the biomedical field. His research and inventions have the potential to make a significant impact on the treatment of Alzheimer's disease, showcasing his dedication to improving healthcare.
Collaborations
He has collaborated with notable colleagues such as Ih-Jen Su and Kuen-Jer Tsai. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in research.
Conclusion
Hong-Yi Chang's work in developing curcumin derivatives for Alzheimer's treatment exemplifies the importance of innovation in medicine. His contributions not only advance scientific knowledge but also hold the potential to improve the lives of many individuals affected by this disease.